Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients.

Boucher, Yves; Kumar, Ashwin S; Posada, Jessica M; Gjini, Evisa; Pfaff, Kathleen; Lipschitz, Mikel; Lako, Ana; Duda, Dan G; Rodig, Scott J; Hodi, F Stephen; Jain, Rakesh K

Boucher, Yves; Kumar, Ashwin S; Posada, Jessica M; Gjini, Evisa; Pfaff, Kathleen; Lipschitz, Mikel; Lako, Ana; Duda, Dan G; Rodig, Scott J; Hodi, F Stephen; Jain, Rakesh K.

Afiliación

Boucher Y; Edwin L. Steele Laboratories, Department of Radiation Oncology Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. yves@steele.mgh.harvard.edu.
Kumar AS; Edwin L. Steele Laboratories, Department of Radiation Oncology Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Posada JM; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Gjini E; Edwin L. Steele Laboratories, Department of Radiation Oncology Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Pfaff K; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Lipschitz M; Center for Immuno-oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Lako A; Bristol Myers Squibb, Cambridge, MA, USA.
Duda DG; Center for Immuno-oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Rodig SJ; Center for Immuno-oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Hodi FS; Center for Immuno-oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Jain RK; Bristol Myers Squibb, Cambridge, MA, USA.

NPJ Precis Oncol ; 5(1): 62, 2021 Jun 29.

Article en En | MEDLINE | ID: mdl-34188163

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google